Building a better particle: Leveraging physicochemical understanding of amorphous solid dispersions and a hierarchical particle approach for improved delivery at high drug loadings.


Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
25 Mar 2019
Historique:
received: 13 11 2018
revised: 03 01 2019
accepted: 07 01 2019
pubmed: 18 1 2019
medline: 14 6 2019
entrez: 18 1 2019
Statut: ppublish

Résumé

Amorphous solid dispersions are a promising option for managing compounds with poor aqueous solubility. However, for compounds with high melting points, thermal stability limitations, or poor solubility in volatile solvents, conventional routes of hot melt extrusion or spray drying may not be viable. Co-precipitated amorphous dispersions (cPAD) can provide a solution. For the material studied in this paper, the cPAD material that was seemingly identical to spray dried material in terms of being single phase amorphous (as measured by DSC and XRD ) but showed slower dissolution behavior. It was identified that physical properties of the cPAD material could be improved to enhance wettability and improve dissolution performance. This was achieved by incorporating the cPAD material into a matrix of water soluble excipients generated via evaporative isolation routes. Importantly, this approach appears to offer another route to further increase the drug load in final dosage units and is significant as increased drug loading generally results in slower or incomplete release. Results showed successful proof of concept via in vitro biorelevant dissolution and confirmatory canine pharmacokinetic studies yielding comparable exposure for capsules comprised of conventional spray dried material as well as capsules with elevated drug load comprised of cPAD hierarchical particles.

Identifiants

pubmed: 30654058
pii: S0378-5173(19)30035-3
doi: 10.1016/j.ijpharm.2019.01.009
pii:
doi:

Substances chimiques

Drug Carriers 0
Excipients 0
Pharmaceutical Preparations 0
Polymers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

147-155

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Luke Schenck (L)

Particle Engineering Labs, Chemical Engineering R&D, Merck & Co., Inc, Rahway, NJ 07065, USA. Electronic address: Luke.Schenck@Merck.com.

Amanda K P Mann (AKP)

Department of Analytical Sciences, Pharmaceutical Sciences, Merck & Co., Inc, Rahway, NJ 07065, USA. Electronic address: Amanda.Mann@Merck.com.

Zhen Liu (Z)

Preformulation, Pharmaceutical Sciences Merck & Co., Inc, West Point, PA 19486, USA.

Mikolaj Milewski (M)

Biopharmaceutics and Specialty Dosage Forms, Pharmaceutical Sciences, Merck & Co., Inc, West Point, PA 19486, USA.

Siwei Zhang (S)

MMC, Process Research and Design, Merck & Co., Inc, Rahway, NJ 07065, USA.

Jie Ren (J)

OFST, Pharmaceutical Sciences, Merck & Co., Inc, West Point, PA 19486, USA.

Kristel Dewitt (K)

Department of Analytical Sciences, Pharmaceutical Sciences, Merck & Co., Inc, Rahway, NJ 07065, USA.

Andre Hermans (A)

Department of Analytical Sciences, Pharmaceutical Sciences, Merck & Co., Inc, Rahway, NJ 07065, USA.

Aaron Cote (A)

Technology Labs, Chemical Engineering R&D, Merck & Co., Inc, Rahway, NJ 07065, USA.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Humans Pharmaceutical Preparations Drug Utilization Prescription Drugs
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Classifications MeSH